Balyasny Asset Management
GMED icon

Balyasny Asset Management’s Globus Medical GMED Stock Holding History

Balyasny Asset Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-150,000
Closed -$7.43M – 1474
2020
Q3 		$7.43M Buy
+150,000
New +$7.74M 0.05% 480

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Balyasny Asset Management's GMED Position: Q1 2026 in Review

Balyasny Asset Management opened a new position in Globus Medical (GMED) in Q1 2026: 63,487 shares worth $5.47M. The stake represents 0.01% of the portfolio and ranks #1332 among its holdings. This is a return to the name: Balyasny Asset Management previously reported a position in GMED as recently as Q1 2025.

Balyasny Asset Management first reported a position in GMED in Q2 2013 and has held it in 22 quarters since. The position peaked at $32.8M in Q1 2022. 603 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Balyasny Asset Management held 63,487 shares of Globus Medical worth $5.47M as of Q1 2026.
  • Globus Medical was a new Balyasny Asset Management position in Q1 2026.
  • Globus Medical made up 0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1332 holding.
  • Balyasny Asset Management first reported a position in Globus Medical in Q2 2013 and has held it in 22 quarters since.
  • Balyasny Asset Management's Globus Medical position peaked at $32.8M in Q1 2022.
  • 603 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.